non-Hodgkin lymphoma depends on each patient's specific situation, but in general, the five-year relative survival rate for Hodgkin lymphoma is higher than that of non-Hodgkin lymphoma. One reason may be that non-Hodgkin lymphoma is often diagnosed when the cancer is more advanced.
“T-cell non-Hodgkin lymphomas tend to be more aggressive,” Strati says.
The primary difference between Hodgkin and non-Hodgkin lymphoma is the type of lymphocyte that is affected. Hodgkin lymphoma is marked by the presence of Reed-Sternberg lymphocytes, which a physician can identify using a microscope. In non-Hodgkin lymphoma, these cells are not present.
Burkitt lymphoma: Considered the most aggressive form of lymphoma, this disease is one of the fastest growing of all cancers. Burkitt lymphoma, named for the surgeon who first identified the cancer in the 1950s, accounts for about 2 percent of all lymphoma diagnoses.
Lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
This is a rare, slow-growing type of lymphoma. It's found mainly in the bone marrow, lymph nodes, and spleen. This type of lymphoma can't be cured.
Overall, treatment for Hodgkin lymphoma is highly effective and most people with the condition are eventually cured.
Leukemia and lymphoma are easily confused because they're both types of blood cancer. Leukemia usually occurs in bone marrow, while lymphoma originates in the lymphatic system and mainly targets lymph nodes and lymph tissue.
The occurrence of HD and NHL in an individual is unusual. Tumour biological features common to both HD and NHL may indicate a similar cellular origin, regardless of the time interval between the diagnoses, and may contribute to the understanding of the pathogenesis of lymphoma.
Hodgkin lymphoma is a type of lymphoma cancer of lymphocytes. Hodgkin lymphoma differs from non-Hodgkin lymphoma because it has a specific kind of abnormal lymphocyte called a Reed-Sternberg cell. Hodgkin lymphoma is also known as Hodgkin's disease, although it is more accurate to refer to as Hodgkin lymphoma.
Hodgkin lymphoma is a relatively aggressive cancer and can quickly spread through the body. Despite this, it's also one of the most easily treated types of cancer. Your recommended treatment plan will depend on your general health and age, because many of the treatments can put a tremendous strain on the body.
Survival for all non-Hodgkin lymphomas
around 80 out of every 100 people (around 80%) survive their cancer for 1 year or more after they are diagnosed. around 65 out of every 100 people (around 65%) survive their cancer for 5 years or more after diagnosis.
The actor Sam Neill has revealed he has had "a ferocious type of aggressive" non-Hodgkin lymphoma. The Jurassic Park star, 75, was diagnosed with Stage three cancer in March 2022 and thought: "I'm crook, I'm dying."
Stage 3 lymphoma is treatable and often curable.
The survival rate of stage 4 lymphoma is lower than that of the other stages, but doctors can cure the condition in some cases. People with a diagnosis of stage 4 lymphoma should discuss their treatment options and outlook with their doctor.
Some survivors of Hodgkin lymphoma have a higher risk of developing a secondary cancer, especially acute myeloid leukemia (after certain types of chemotherapy, like BEACOPP), non-Hodgkin lymphoma, lung cancer, or breast cancer.
by Dr. C.H. Weaver M.D. updated 5/2023. Compared to individuals in the general population, patients with non-Hodgkin's lymphoma are at increased risk of developing a second cancer, particularly leukemia, lung, and skin cancers.
Hodgkin lymphoma isn't infectious and isn't thought to run in families. Although your risk is increased if a first-degree relative (parent, sibling or child) has had lymphoma, it's not clear if this is because of an inherited genetic fault or lifestyle factors.
Non-Hodgkin lymphoma is caused by a change (mutation) in the DNA of a type of white blood cell called lymphocytes, although the exact reason why this happens isn't known. DNA gives cells a basic set of instructions, such as when to grow and reproduce.
Non-Hodgkin's lymphoma generally involves the presence of cancerous lymphocytes in your lymph nodes. But the disease can also spread to other parts of your lymphatic system. These include the lymphatic vessels, tonsils, adenoids, spleen, thymus and bone marrow.
NHL is a serious condition but commonly has a relatively promising outlook. Most people with NHL survive at least 5 years after a diagnosis. However, older people are more likely to die from the condition. Other factors that affect the outlook include the stage and spread of the cancer.
Around 90 out of 100 people (around 90%) will survive their Hodgkin lymphoma for 5 years or more after diagnosis.
The 5-year relative survival rate of people with localized Hodgkin lymphoma is 93%. If the cancer spreads regionally, the 5-year relative survival rate is 95%. If the cancer has spread to different parts of the body, the 5-year relative survival rate is 83%.